<DOC>
	<DOCNO>NCT02969109</DOCNO>
	<brief_summary>A study validate , prospective manner , ability predefined Genomic Health bladder cancer assay detect recurrence patient undergoing surveillance non-muscle invasive bladder cancer .</brief_summary>
	<brief_title>Validation Urine-based Assay With Genomic Markers Predicting Recurrence Non-muscle Invasive Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Patients prior diagnosis nonmuscle invasive , â‰¤T1 , urothelial cell carcinoma bladder schedule undergo surveillance cystoscopy . Patients young 18 year Patients diagnosis small cell carcinoma , adenocarcinoma squamous cell carcinoma bladder Patients cystectomy prior diagnosis muscle invasive disease ( T2 great ) Patients unable unwilling give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>